A case of vasculitis in a breast cancer patient treated with T-DM1, Seminars in Oncology, vol.41, pp.39-45, 2014. ,
T-DM1-related carotenoderma and hand-foot syndrome, Lancet, vol.385, pp.1509-1510, 2015. ,
The use of propranolol in the treatment of infantile haemangiomas: An update on potential mechanisms of action, The British Journal of Dermatology, vol.172, pp.24-32, 2015. ,
Telangiectasia and pulmonary arterial hypertension following treatment with trastuzumab emtansine: A case report, Chest, vol.149, pp.103-105, 2016. ,
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway, Pediatric Blood & Cancer, vol.62, pp.1414-1420, 2015. ,
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: A case series, Breast Cancer Research and Treatment, vol.146, pp.451-456, 2014. ,
T-DM1-related telangiectasias: A potential role in secondary bleeding events, Annals of Oncology, vol.26, pp.436-437, 2015. ,
Trastuzumab emtansine for HER2-positive advanced breast cancer, The New England Journal of Medicine, vol.367, pp.1783-1791, 2012. ,
, FIGURE 2 (a) Telangiectasias on the left arm before treatment with propranolol, taking the appearance of spider angiomas in some locations